BROOKE MCBRIDE: Open Payments
NPI 1548720063 · MAYFIELD, NY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,206 in 74 payments from 18 companies in 2025. Trend: 2023 $309 · 2024 $157 · 2025 $1,206
Food & beverage: $1,206
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 22 | $267 |
| AstraZeneca Pharmaceuticals LP | 5 | $215 |
| PFIZER INC. | 16 | $156 |
| Lilly USA, LLC | 7 | $122 |
| Novo Nordisk Inc | 4 | $89 |
| Sumitomo Pharma America, Inc. | 4 | $74 |
| Axsome Therapeutics, Inc. | 2 | $43 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $40 |
| Astellas Pharma US Inc | 2 | $37 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 1 | $27 |
Products named: AIRSUPRA, NURTEC ODT, UBRELVY, GEMTESA, QULIPTA, VRAYLAR, KISUNLA, Rybelsus.
Industry payments across NY — which companies pay providers there.
